FTSE Russell Analytics

content.title.value
FTSE Russell Analytics

PDF, 456.44KB, 4 pages

Download
Download

Share price analysis relative to sector and index performance.

Company tear sheet

content.image.label
Company tear sheet

PDF, 59.46KB, 7 pages

Download
Download

Full issuer details available in a single file ready for sharing.

HUTCHMED (China) Limited news

Show all news
Sort by
Show 20 news
137 results (20 showing)
HeadlineSourceDateTime
Blocklisting Six Monthly Return
RNS
31 December 2021
07:00:04
RNS 31.12.21 07:00:04
Total Voting Rights
RNS
31 December 2021
07:00:03
RNS 31.12.21 07:00:03
HUTCHMED Included in FTSE Russell Indexes
Reach
20 December 2021
07:00:08
Reach 20.12.21 07:00:08
Grant of Share Options and Awards under LTIP
RNS
15 December 2021
09:45:01
RNS 15.12.21 09:45:01
HMPL-523 Clinical Data Presented at ASH
Reach
14 December 2021
07:00:11
Reach 14.12.21 07:00:11
HUTCHMED Presents Data at ESMO Immuno-Oncology ‘21
Reach
10 December 2021
10:00:01
Reach 10.12.21 10:00:01
HUTCHMED Completes Planned Enrollment of FRESCO-2
Reach
06 December 2021
07:00:09
Reach 06.12.21 07:00:09
Updated NRDL to include ELUNATE and SULANDA
RNS
03 December 2021
07:00:04
RNS 03.12.21 07:00:04
Total Voting Rights
RNS
30 November 2021
08:30:05
RNS 30.11.21 08:30:05
HUTCHMED and AZ Initiate SACHI Phase 3 Trial
Reach
24 November 2021
07:00:04
Reach 24.11.21 07:00:04
HUTCHMED to Present Clinical Data at ASH
Reach
08 November 2021
07:00:09
Reach 08.11.21 07:00:09
HUTCHMED and AZ Initiate SAMETA Global P3 Trial
Reach
01 November 2021
07:00:14
Reach 01.11.21 07:00:14
Total Voting Rights
RNS
29 October 2021
09:30:02
RNS 29.10.21 09:30:02
HUTCHMED Initiates Phase III Trial of HMPL-523
Reach
28 October 2021
07:00:04
Reach 28.10.21 07:00:04
Grant of Awards under Long Term Incentive Plan
RNS
20 October 2021
09:30:03
RNS 20.10.21 09:30:03
Total Voting Rights
RNS
30 September 2021
09:30:07
RNS 30.09.21 09:30:07
HUTCHMED Highlights Presentations at CSCO 2021
Reach
29 September 2021
07:00:10
Reach 29.09.21 07:00:10
Closure of Non-Core OTC Joint Venture Divestment
Reach
29 September 2021
07:00:10
Reach 29.09.21 07:00:10
HUTCHMED Initiates Phase III Trial SURTORI-01
Reach
21 September 2021
07:00:10
Reach 21.09.21 07:00:10
Japan Bridging Study For Surufatinib Initiated
Reach
20 September 2021
07:00:09
Reach 20.09.21 07:00:09